EUVIMEDEUVIMED entdecken
Crossref

Bismuth Sulfide Nanoflowers Facilitated miR339 Delivery to Overcome Stemness and Radioresistance through Ubiquitin-Specific Peptidase 8 in Esophageal Cancer

Xuantong Zhou, Fene Gao, Wenyan Gao, Qingzhen Wang, Xin Li, Xinyue Li, Wenxin Li, Jing Liu iD, Huige Zhou iD, Aiping Luo, Chunying Chen iD, Zhihua Liu

ACS Nano · 23.07.2024 · 18 (29) · 19232-19246

DOI: 10.1021/acsnano.4c05100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 12.07.2024. Verfasst von Xuantong Zhou und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical …. Hauptthemen laut MEDLINE: Bismuth, MicroRNAs, Esophageal Neoplasms, Sulfides. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Key Research Program of Frontier Science, Chinese Academy of Sciences, Chinese Academy of Medical Sciences, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the superior efficacy of radiotherapy in esophageal squamous cell carcinoma (ESCC), radioresistance by cancer stem cells (CSCs) leads to recurrence, metastasis, and treatment failure. Therefore, it is necessary to develop CSC-based therapies to enhance radiotherapy. miR-339-5p (miR339) is involved in stem cell division and DNA damage checkpoint signaling pathways based on ESCC cohort. miR339 inhibited ESCC cell stemness and enhanced radiation-induced DNA damage by targeting USP8, suggesting that it acts as a potential CSC regulator and radiosensitizer. Considering the limited circulating periods and poor tumor-targeting ability of miRNA, a multifunctional nanoplatform based on bismuth sulfide nanoflower (Bi@PP) is developed to efficiently deliver miR339 and improve radioresistance. Intriguingly, Bi@PP encapsulates more miR339 owing to their flower-shaped structure, delivering more than 1000-fold miR339 into cells, superior to free miR339 alone. Besides being used as a carrier, Bi@PP is advantageous for dynamically monitoring the distribution of delivered miR339 in vivo while simultaneously inhibiting tumor growth. Additionally, Bi@PP/miR339 can significantly enhance radiotherapy efficacy in patient-derived xenograft models. This multifunctional platform, incorporating higher miRNA loading capacity, pH responsiveness, hypoxia relief, and CT imaging, provides another method to promote radiosensitivity and optimize ESCC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BismuthMicroRNAsEsophageal NeoplasmsSulfidesNeoplastic Stem CellsHumansAnimalsMiceRadiation ToleranceUbiquitin ThiolesteraseMice, NudeMice, Inbred BALB CCell ProliferationCell Line, TumorEsophageal Squamous Cell Carcinoma

Stichwörter der Autor:innen

Bi@PP/miR339bismuth sulfide nanoflowerscancer stem cellsesophageal squamous cell carcinomaradioresistanceubiquitin-specific peptidase 8

Substanzen

BismuthMicroRNAsSulfidesbismuth sulfideUbiquitin Thiolesterase

Autor:innen und Institutionen

  • State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • New Cornerstone Science Laboratory, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing…
  • Research Unit of Nanoscience and Technology, Chinese Academy of Medical Sciences, Beijing 100021, China.

ORCID-Profile: Jing Liu, Huige Zhou, Chunying Chen

Förderung

  • Key Research Program of Frontier Science, Chinese Academy of Sciences
  • Chinese Academy of Medical Sciences
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Chinese Academy of Sciences
  • New Cornerstone Science Foundation

Zitieren

APA

Zhou, X., Gao, F., Gao, W., Wang, Q., Li, X., Li, X., Li, W., Liu, J., Zhou, H., Luo, A., Chen, C., & Liu, Z. (2024). Bismuth Sulfide Nanoflowers Facilitated miR339 Delivery to Overcome Stemness and Radioresistance through Ubiquitin-Specific Peptidase 8 in Esophageal Cancer. ACS Nano, 18(29), 19232-19246. https://doi.org/10.1021/acsnano.4c05100

Vancouver

Zhou X, Gao F, Gao W, Wang Q, Li X, Li X, et al. Bismuth Sulfide Nanoflowers Facilitated miR339 Delivery to Overcome Stemness and Radioresistance through Ubiquitin-Specific Peptidase 8 in Esophageal Cancer. ACS Nano. 2024;18(29):19232-19246. doi:10.1021/acsnano.4c05100

BibTeX
@article{Zhou2024,
  author = {Zhou, Xuantong and Gao, Fene and Gao, Wenyan and Wang, Qingzhen and Li, Xin and Li, Xinyue and Li, Wenxin and Liu, Jing and Zhou, Huige and Luo, Aiping and Chen, Chunying and Liu, Zhihua},
  title = {Bismuth Sulfide Nanoflowers Facilitated miR339 Delivery to Overcome Stemness and Radioresistance through Ubiquitin-Specific Peptidase 8 in Esophageal Cancer},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {29},
  pages = {19232--19246},
  doi = {10.1021/acsnano.4c05100}
}
Kostenlos starten →